The expression of dual oxidase, thyroid peroxidase, and caveolin-1 differs according to the type of immune response (TH1/TH2) involved in thyroid autoimmune disorders

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1722-1732

  Marique, Lancelot ^a   Van Regemorter, Victoria ^a   Gérard, Anne Catherine ^a   Craps, Julie ^a   Senou, Maximin ^a   Marbaix, Etienne ^a   Rahier, Jacques ^a   Daumerie, Chantal ^a   Mourad, Michel ^b   Lengelé, Benoît ^a   Colin, Ides M ^a   Many, Marie Christine ^a  

^a Institut de Recherches Expérimentales et Cliniques   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; DUAL OXIDASE; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; LUGOL; OXIDOREDUCTASE; PROPYLTHIOURACIL; THIAMAZOLE; THYROID PEROXIDASE; THYROXINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOACCUMULATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TH1 CELL; TH2 CELL; THYROID CELL; THYROID FOLLICLE;

ADULT; APOPTOSIS; AUTOANTIBODIES; CAVEOLIN 1; CELL PROLIFERATION; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; NADPH OXIDASE; OXIDATIVE STRESS; THYROID GLAND;

EID: 84899967474     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3469     Document Type: Article

References (40)

1. Mizukami Y, Michigishi T, Hashimoto T, Tonami N, Matsubara F, Takazakura E. Silent thyroiditis: a histologic and immunohistochemical study. Hum Pathol. 1988;19:423-431.
2. Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves'disease (Th2). Neuroimmunomodulation. 2004;11:209-213.
3. Gerard AC, Boucquey M, van den Hove MF, Colin IM. Expression of TPO and ThOXs in human thyrocytes is downregulated by IL-1-/IFN-, an effect partially mediated by nitric oxide. Am J Physiol Endocrinol Metab. 2006;2 91:242-253.
4. Ajjan RA, Watson PF, Findlay C, et al. The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J Endocrinol. 1998;158:351-358.
5. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev. 1994;15:788-830.
6. De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid. 2011;21:879-891.
7. De Vito P, Balducci V, Leone S, et al. Nongenomic effects of thyroid hormones on the immune system cells: new targets, old players. Steroid. 2012;77:988-995.
8. Colin IM, Denef JF, Lengele B, Many MC, Gerard AC. Recent insights into the cell biology of thyroid angiofollicular units. Endocr Rev. 2013;34:209-238.
9. Song Y Driessens N Costa M et al. Roles of hydrogen peroxide in thyroid physiology and diseaseJ Clin Endocrinol Metab. 2007 92 3764-3773.
10. Senou M, Costa MJ, Massart C, et al. Role of caveolin-1 in thyroid phenotype, cell homeostasis, and hormone synthesis: in vivo study of caveolin-1 knockout mice.AmJ Phy siol Endocrinol Metab. 2009; 297:438-451.
11. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell. 1992;68:673-682.
12. Glenney JR Jr., Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA. 1992;89:10517-10521.
13. Harvey RD, Calaghan SC. Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J Mol Cell Cardiol. 2012;52(2):366-375.
14. Senou M, Khalifa C, Thimmesch M, et al. A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid. J Clin Endocrinol Metab. 2010;95:4021-4030.
15. Ratajcaak P, Oliviéro P, Marotte F, Kolar F, Ostadal B, Samuel JL. Expression and localization of caveolins during postnatal development in rat heart : implication of thyroid hormone. J Appl Physiol. 2005;99:244-251.
16. Nilsson M, Husmark J, Nilsson B, Tisell LE, Ericson LE. Primary culture of human thyrocytes in Transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Eur J Endocrinol. 1996;135:469-480.
17. Gerard AC, Xhenseval V, Colin IM, Many MC, Denef JF. Evidence for co-ordinated changes between vascular endothelial growth factor and nitric oxide synthase III immunoreactivity, t he functional status of the thyroid follicles, and the microvascular bed during chronic stimulation by low iodine and propylthiouracyl in old mice. Eur J Endocrinol. 2000;142:651-660.
18. Gerard AC, Many MC, Daumerie C, et al. Structural changes in the angiofollicular units between active and hypofunctioning follicles align with differences in the epithelial expression of newly discovered proteins involved in iodine transport and organification. J Clin Endocrinol Metab. 2002;87:1291-1299.
19. Costa MJ, Song Y, Macours P, et al. Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling. Endocrinology. 2004;1 45:1464-1472.
20. Poncin S, Gerard AC, Boucquey M, et al. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology. 2008;149:424-433.
21. Poncin S, Lengele B, Colin IM, Gerard AC. Differential interactions between Th1/Th2, Th1/Th3, and Th2/Th3 cytokines in the regulation of thyroperoxidase and dual oxidase expression, and of thyroglobulin secret ion in thyrocytes in vitro. Endocrinology. 2008;149: 1534-1542.
22. Yang D, Yuan Z, Li C. [Gene expression of thyrotropin receptor, thyroid peroxidase and thyroglobulin in autoimmune thyroid disease]. Zhonghua Nei Ke Za Zhi. 1997;36:685-688.
23. Song Y, Lothaire P, Dequanter D, et al. Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. J Clin Endocrinol Metab. 2010;95:375-382.
24. Razani B, Lisanti MP. Caveolins and caveolae: molecular and functional relationships. Exp Cell Res. 2001;271:36-44.
25. Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001;293:2449-2452.
26. Lei MG, Tan X, Qureshi N, Morrison DC. Regulation of cellular caveolin-1 protein expression in murine macrophages by microbial products. Infect Immun. 2005;73:8136-8143.
27. van den Hove MF, Stoenoiu MS, Croizet K, et al. Nitric oxid e is involved in interleukin-1-induced cytotoxicity in polarised human thyrocytes. J Endocrinol. 2002;173:177-185.
28. Raad H, Eskalli Z, Corvilain B, Miot F, De Deken X. Thyroid hydrogen pe roxide production is enhanced by the Th2 cytokines, IL-4 and IL-13, through increased expression of the dual oxidase 2 and its maturation factor DUOXA2. Free Radic Biol Med. 2013;56: 216-225.
29. Poncin S, C olin IM, Decallonne B, et al. N-acetylcysteine and 15 deoxy-12,14-prostaglandin J2 exert a protective effect against autoimmune thyroid destruction in vivo but not against interleukin-1-/interferon-induced inhibitory effects in thyrocytes in vitro. Am J Pathol. 2010;177:219-228.
30. Bedard K, Krause KH. The NOX family of ROS-generating NADPHoxidases: physiology and pathophysiology. Physiol Rev. 2007; 87:245-313.
31. Weyemi U Caillou B Talbot M et al.i Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues Endocr Relat Cancer. 2010 17:27-37
32. Colin IM, Poncin S, Levê que P, Gallez B, Gérard AC. Differential regulation of the production of reactive oxygen species in Th1 cytokine-treated thyroid cells [published online December 13, 2013]. Thyroid. doi:10.1089/thy .2013.0142.
33. Kohrle J, Jakob F, Contempre B, Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev. 2005;26:944-984.
34. Kohrle J, Gartner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23:815-827.
35. Davies CM, Guilak F, Weinberg JB, Fermor B. Reactive nitrogen an d oxygen species in interleukin-1-mediated DNA damage associated with osteoarthritis. Osteoarthritis Cartilage. 2008;16:624-630.
36. Suarez-Pinzon WL, Strynadka K, Schulz R, Rabinovitch A. Mechan isms of cytokine-induced destruction of rat insulinoma cells: The role of nitric oxide. Endocrinology. 1994;134:1006-1010.
37. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Lakey JR, Rajotte RV. Human pancreatic islet-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J Clin Endocrinol Metab. 1996;81:3197-3202.
38. Costa MJ, Senou M, Van Rode F, et al. Reciprocal negative regulation between thyrotropin/3-,5-cyclic adenosine monophosphatemediated proliferation and caveolin-1 expression in human and murine thyrocytes. Mol Endocrinol. 2007;21:921-932.
39. Hu lit J, Bash T, Fu M, et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem. 2000;275:21203-21209.
40. Gerard AC, Many MC, Daumerie C, Knoops B, Colin IM. Peroxiredoxin 5 expression in the human thyroid gland. Thyroid. 2005; 15:205-209.